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Acrofacial Dysostosis, Cincinnati Type,
a Mandibulofacial Dysostosis Syndrome
with Limb Anomalies, Is Caused by POLR1A Dysfunction
K. Nicole Weaver,1,9,* Kristin E. Noack Watt,2,3,9 Robert B. Hufnagel,1 Joaquin Navajas Acedo,2
Luke L. Linscott,4 Kristen L. Sund,1 Patricia L. Bender,1 Rainer Ko¨nig,5 Charles M. Lourenco,6
Ute Hehr,7 Robert J. Hopkin,1 Dietmar R. Lohmann,8 Paul A. Trainor,2,3,10 Dagmar Wieczorek,8,10
and Howard M. Saal1,10
We report three individuals with a cranioskeletal malformation syndrome that we define as acrofacial dysostosis, Cincinnati type. Each
individual has a heterozygousmutation in POLR1A, which encodes a core component of RNA polymerase 1. All three individuals exhibit
varying degrees of mandibulofacial dysostosis, and two additionally have limb anomalies. Consistent with this observation, we discov-
ered that polr1a mutant zebrafish exhibited cranioskeletal anomalies mimicking the human phenotype. polr1a loss of function led to
perturbed ribosome biogenesis and p53-dependent cell death, resulting in a deficiency of neural-crest-derived skeletal precursor cells
and consequently craniofacial anomalies. Our findings expand the genotypic and phenotypic heterogeneity of congenital acrofacial dis-
orders caused by disruption of ribosome biogenesis.Introduction
The skeleton provides a structural framework in vertebrates
for muscle attachments, facilitating movement, protecting
vital organs, and maintaining homeostasis of the immune
and vascular systems. Perturbation of bone development
results in congenital craniofacial and skeletal anomalies,
which affect approximately 1 in 3,000 live births.1 One
specific type of congenital skeletal disorder, termed facial
dysostosis, describes a set of clinically and etiologically het-
erogeneous anomalies of the craniofacial skeleton, and
they arise as a consequence of abnormal development of
the first and second pharyngeal arches and their deriva-
tives during embryogenesis. Mandibulofacial dysostosis
and acrofacial dysostosis are subgroups of human facial
dysostoses.2 The best-understood mandibulofacial dysos-
tosis, Treacher Collins syndrome (MIM: 154500), is a
genetically heterogeneous disorder caused by mutations
in at least three genes—TCOF1 (MIM: 606847), POLR1C
(MIM: 610060), and POLR1D (MIM: 613715)—which regu-
late rDNA transcription and ribosome biogenesis.3–5 The
acrofacial dysostoses, which include at least six genetically
and phenotypically distinct subtypes,2 encompass similar
craniofacial anomalies with the addition of limb defects.6
Moreover, perturbed ribosome biogenesis has also been
associated with the pathogenesis of acrofacial dysostosis,
Nager type (MIM: 154400).7,81Division of Human Genetics, Department of Pediatrics, Cincinnati Children’s
MLC 4006, 3333 Burnet Avenue, Cincinnati, OH 45229, USA; 2Stowers Institu
3University of Kansas Medical Center, Kansas City, MI 66160, USA; 4Departme
OH 45229, USA; 5Institut fu¨r Humangenetik, Universita¨tsklinikum Frankfur
Clinics Hospital of Ribeirao Preto, University of Sao Paulo, Avenue Bandeirant
sita¨tsklinikum Regensburg, Franz-Josef-StrauB-Allee 11, 93053 Regensburg, Ger
Duisburg-Essen, Hufelandstr 55, 45122 Essen, Germany
9These authors contributed equally to this work
10These authors contributed equally to this work
*Correspondence: kathryn.weaver@cchmc.org
http://dx.doi.org/10.1016/j.ajhg.2015.03.011. 2015 by The American Societ
The AmHere, we present three individuals with mandibulofacial
dysostosis; two have limb anomalies, and all have putative
pathogenic variants in POLR1A (GenBank: NM_015425.3).
We describe the spatiotemporal expression of polr1a in
zebrafish and characterize the phenotype of zebrafish
with polr1a loss of function. Further studies demonstrated
that altered POLR1A function has deleterious effects on
ribosome biogenesis. Our findings document acrofacial
dysostosis, Cincinnati type as a syndrome characterized
by a spectrum of mandibulofacial dysostosis phenotypes
(with or without extrafacial skeletal defects) caused by
abnormal function of POLR1A.Material and Methods
Whole-Exome Sequencing
DNA specimens were collected according to protocols approved by
the institutional review board at Cincinnati Children’s Hospital
Medical Center. Informed consent for DNA storage and genetic
analyses was obtained from all subjects. Whole-genome DNA
was extracted from whole blood by standard methods. Library
construction was performed on double-stranded DNA (sheared
by sonication to an average size of 200 bp) in an automated
fashion on an IntegenX Apollo324. After nine cycles of PCR
amplification by the Clontech Advantage II Kit, 1 mg of
genomic library was recovered for exome enrichment with the
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Illumina HiSeq 2500, generating approximately 30million paired-
end reads, each 100 bases long. Data analysis utilized the Broad
Institute’s Genome Analysis Toolkit (GATK).9 Reads were aligned
with the Illumina Chastity Filter with the Burrows-Wheeler
Aligner (BWA).10 Variant sites were called with the GATK
UnifiedGenotyper module. Single-nucleotide-variant calls were
filtered by variant quality-score recalibration.9 Filtering of variants
was performed with Golden Helix’s SNP & Variation Suite.
Sanger Sequencing
Sanger sequencing was performed by standard methods on exons
1–34 of POLR1A. Primers were designed with Primer3 and are
listed in Tables S1 and S2. PCR products were amplified with
50 ng of DNA and standard PCR reagents on an ABI Veriti Thermo-
cycler (Applied Biosystems). PCR products were precipitated, and
sequencing PCR was performed with BigDye Terminator Ready
Reaction Mix (ABI Biosystems).
Clustal Omega was used for analysis of homology between hu-
man and Saccharomyces cerevisiae A190 proteins.11–13
Zebrafish Embryos
Zebrafish (Danio rerio) embryos were raised at 28.5C and staged as
described in Kimmel et al.14 The AB strain was used as the wild-
type strain. Heterozygous polr1ahi3639Tg fish15,16 were identified
with primers 50-CTCCCAGAACACAGTCACACG-30 and 50-GCTA
GCTTGCCAAACCTACAGGT-30 and incrossed for the generation
of homozygous mutant embryos. Homozygous mutant embryos
were identified bymorphology and then confirmed by PCR. Trans-
genic Tg(7.2 kb-sox10:gfp) zebrafish,17 referred to as sox10:gfp, were
crossed to polr1a heterozygotes for visualization of neural crest
cells (NCCs) in polr1a mutant embryos and controls.
Phenotypic Analyses
In situ hybridization was performed according to standard proto-
cols. A portion of polr1a was amplified with primers 50-CTCC
GCTGATGAAACAAGAAA-30 (forward) and 50-CAAACGATTAA
TAGGCCTGTACCTG-30 (reverse) and cloned into the TOPO II vec-
tor (Invitrogen), which was used for generating the polr1a probe.
Embryos were mounted and imaged with a Leica MZ16 micro-
scope equipped with a Nikon DS-Ri1 camera and NIS Elements
BR 3.2 imaging software.
Alcian blue and Alizarin red staining were performed as
described in Walker and Kimmel18 and imaged with the same sys-
tem described previously.
Immunostaining for HuC (1:200; Invitrogen) and Sox10 (1:500;
Genetex) with Alexa 488 secondary antibody (1:500; Invitrogen)
was performed as described in Westerfield.19 TUNEL was
completed as described in Crump et al.20 with slight modifica-
tions. Embryos were permeabilized overnight in methanol at
20C and incubated for 1 hr at 37C in a reaction mixture
containing TdT and TMR red. Embryos were imaged with a Zeiss
upright 700 confocal microscope, and images were taken and pro-
cessed with Zen software.
Molecular Analyses
RNA was collected from zebrafish at 24 hr post-fertilization (hpf)
with the QIAGEN miRNeasy Micro Kit and was tested for quality
on an Agilent 2100 Bioanalyzer. The Superscript III Kit (Invitro-
gen) was used to synthesize cDNA for qRT-PCR. Primers for polr1a
were 50-CACCTGGAGAAGAAATCCAAG-30 and 50-GATGTGCTT
GACAGGGTCAG-30, and primers for tp53 were 50-CGAGCCACT766 The American Journal of Human Genetics 96, 765–774, May 7, 2GCCATCTATAAG-30 and 50-TGCCCTCCACTCTTATCAAATG-30.
rRNA primer sequences were obtained from Azuma et al.21 Power
Sybr (Life Technologies) reaction mix and the ABI 7900HT real-
time PCR cycler were used for measuring cDNA amplification.
Data were analyzed with Biogazelle software, and the Mann-
Whitney test was used for determining statistical significance.
Protein samples of 100 fish/sample were collected at 24 hpf and
4 days post-fertilization (dpf). 24-hpf zebrafishwere deyolked prior
to protein extraction. Embryos were homogenized and suspended
in sample buffer according to standard protocols.19 Primary anti-
bodies used were zebrafish Tp53 (1:500, Anaspec) and a-tubulin
(1:10,000, Sigma). Fluorescent secondary antibodies (Alexa 680
anti-mouse and Alexa 800 anti-rabbit, Invitrogen) were used at a
dilution of 1:20,000. Images were taken with the LICOR system
and then quantified with ImageJ. Tp53 amounts were normalized
to those of a-tubulin, and statistical significance was determined
with Student’s t test.Results
Human Phenotypes
Individual 1A1 is a 3-year-old white male with multiple
prenatally identified craniofacial anomalies, including se-
vere micrognathia, which required tracheostomy at birth
to establish a secure airway. Initial physical exam of the
full-term newborn revealed down-slanting palpebral fis-
sures, severe bilateral lower eyelid clefts, inferiorly dis-
placed orbits, an underdeveloped midface, and extreme
micrognathia (Figures 1A–1C). Bilateral anotia and severe
conductive hearing loss were present. At birth, head
circumference was 33 cm (1.7 SDs), length was 43 cm
(4 SDs), and weight was 2.4 kg (2.5 SDs). Short stature
became more significant with age (height was 76 cm
[5 SDs] at age 3 years). Hypoplasia of the zygomatic
arches, maxilla, and mandible with absent mandibular
rami was seen on a computed-tomography (CT) scan (Fig-
ures 1D and 1E). In addition, individual 1A1 had congen-
ital short bowed femurs with metaphyseal flaring,
dysplastic acetabulae, and delayed or absent ossification
of the capital femoral epiphyses (Figure 1F). His parents
are healthy, and he has no siblings. Individual 1A2, previ-
ously described by Wieczorek et al.,22 is a 6-year-old Brazil-
ian female with craniofacial anomalies including short,
down-slanting palpebral fissures, upper and lower eyelid
clefts, absent medial eyelashes, heminasal aplasia, large
ears, and full lips (Figure 2A). Her facial CT scan demon-
strated hypoplastic zygomata and maxilla and bilateral
choanal atresia, which was more severe on the left side
(Figures 2B and 2C). Growth parameters were significant
for microcephaly (45.5 cm [4.3 SDs]), and height
(110.4 cm [1.4 SDs]) and weight (15.4 kg) were normal.
Individual 1A3 is a 52-year-old German male with facial
dysmorphism including down-slanting palpebral fissures,
malar flattening, micrognathia, and low-set ears with a
unilateral dysplastic helix and accessory tragus (Figures
2D and 2E). On examination, he had short, broad fingers
(Figure 2F) and toes, and his height, weight, and head
circumference were within normal limits. His parents,015
Figure 1. Individual 1A1
(A) Newborn photo demonstrates exten-
sive craniofacial malformations.
(B and C) Frontal and profile images were
taken at age 18 months after multiple
reconstructive surgeries.
(D) 3D reformatted image demonstrates
severe maxillary and zygomatic hypopla-
sia (black open dashed arrow) and severe
micrognathia and retrognathia (white
block arrow).
(E) Axial CTof the temporal bones demon-
strates severe microtia with absent pinnae
(white arrows), external auditory atresia
(white open dashed arrows), and severe
middle-ear hypoplasia and ossicular
dysplasia (black open arrows).
(F) X-ray of individual 1A1 demonstrates
bilateral hip dysplasia and anterior bowing
deformity of the femurs.four siblings, and two sons are healthy. His parents are re-
ported to be consanguineous, but the degree is unknown.
Clinical features of all three affected individuals are sum-
marized in Table 1.
Sequencing Results
Clinical TCOF1 sequencing and SNP microarray (Illumina
HD HumanOmni1-Q uad BeadChip Kit) of individual 1A1
did not identify abnormalities. Individual 1A2 had a
normal karyotype and Affymetrix Cytoscan HD Array.
Additionally, sequencing of TCOF1, POLR1D, POLR1C,
and TXNL4 did not detect pathogenic variants, nor did
multiplex ligation-dependent probe amplification of
TXNL4 and TCOF1. Sequencing of TCOF1 in individual
1A3 did not detect a mutation.
Whole-exome sequencing of individual 1A1 revealed
a de novo heterozygous POLR1A variant (c.1777G>C
[p.Glu593Gln]; GenBank: NM_015425.3), which was vali-
dated by Sanger sequencing (Figure S1A). The variant was
not present in control data from 1000 Genomes,23 the
NHLBI ESP6500 dataset,24 and approximately 300 in-
house control exomes. The affected amino acid is highly
conserved among seven species (Table S3), and the variant
is predicted to be pathogenic by in silico models (Table S4).
Two additional de novo variants were identified in FN1
(MIM: 135600) and KANSL3. Neither variant is predicted
to be pathogenic. KANSL3 mutations are not associated
with a known phenotype. Mutations in FN1 cause auto-
somal-dominant glomerulopathy with fibronectin de-
posits (MIM: 601894), which was not present in individual
1A1. For excluding the possibility of a second genetic diag-
nosis, the exome data were filtered for homozygous reces-
sive and compound-heterozygous variants. No additional
candidate variants were identified (see Table S5 for a break-
down of the filtering strategy and results).
After identification of POLR1A as a candidate gene, tar-
geted Sanger sequencing of POLR1A was performed in 48The Amindividuals with mandibulofacial dysostosis of unknown
genetic etiology. Individual 1A2 had a heterozygous
POLR1A frameshift variant (c.3649delC [p.Gln1217Argfs*
10]; Figure S1B), which was inherited from her father,
who has down-slanting palpebral fissures and mild
malar hypoplasia. Individual IA-3 had a heterozygous
missense variant (c.3895G>T [p.Val1299Phe]) in POLR1A
(Figure S1C). His parents were not available for testing.
The POLR1A variants identified in individuals 1A2 and
1A3 are predicted to be pathogenic by in silico models,
and neither has been reported in control populations
from dbSNP or NHLBI ESP6500 (see Tables S4 and S6 for
in silico predictions and conservation).
Polr1a Expression and Functional Studies
In order to understand how dysfunction of POLR1A causes
skeletal malformations, we investigated the expression and
function of polr1a by using zebrafish as a model. In situ hy-
bridization revealed that polr1a was dynamically expressed
during zebrafish embryogenesis (Figure 3). polr1a expres-
sion was initiated as early as the 2-cell stage and continued
to be ubiquitously expressed until at least 12 hpf. By
18 hpf, the expression of polr1a became enriched in the
eyes and brain. The tissue specificity of polr1a expression
continued at 24 hpf in regions of the brain, eyes, otic ves-
icles, and somites. Beyond 36 hpf, polr1a expression was
diminished throughout the embryo but was maintained
at the midbrain-hindbrain boundary and the ocular lens.
To explore the function of polr1a during craniofacial and
limb development, we examined zebrafish with an inser-
tion mutation15,16 in the 50 UTR of polr1a (polr1ahi3639Tg).
This mutation results in a severe loss of polr1a expression
in homozygous mutant embryos (Figure S2). Early in
development, however, these embryos are not completely
without Polr1a because of the maternal contribution of
polr1a. Homozygous polr1a mutant embryos exhibited
grossmorphological defects from 15 hpf onward (Figure 4).erican Journal of Human Genetics 96, 765–774, May 7, 2015 767
Figure 2. Individuals 1A2 and 1A3
(A) Individual IA2 at 6 years of age.
(B) 3D bone image of individual IA2 dem-
onstrates moderate zygomatic hypoplasia
(white block arrow), midface hypoplasia
with absent nasal bones (white open
arrow), and midline alveolar process hypo-
plasia (open white dashed arrow).
(C) Axial CT image of individual IA2 dem-
onstrates bilateral choanal atresia (white
arrows) and left maxillary and ethmoid
sinus hypoplasia (black arrows).
(D and E) Individual 1A3 at 52 years of age.
Profile and frontal photos demonstrate
subtle craniofacial dysmorphism includ-
ing malar hypoplasia, micrognathia, and
dysplastic ears.
(F) Short, broad fingers of individual IA3.Compared to wild-type controls, the polr1a mutants had
noticeably smaller and misshapen heads. By 24 hpf, the
craniofacial phenotype in polr1a mutant embryos became
more pronounced. Not only was the head considerably
smaller, but the eyes and brain were also abnormally
shaped. In addition, the tail was short and misshapen. A
pattern of dark, grainy cells could be observed in the
head and at the end of the tail, suggestive of cell death as
a component underlying the pathogenesis of the pheno-
type. The phenotype continued to progress such that by
36–48 hpf, polr1a mutant embryos were proportionally
smaller than wild-type controls and exhibited micro-
phthalmia, cerebral hypoplasia, jaw agenesis, perturbed
pigmentation, and abnormal morphology of the heart,
otolith, and pectoral fin. polr1a mutant fish died by
4–5 dpf, and skeletal staining revealed that polr1a mutantTable 1. Key Features of Individuals with POLR1A Mutations
Affected Individual
1A1 1A2
POLR1A mutationa c.1777G>C c.3649delC
POLR1A variant p.Glu593Gln p.Gln1217Argfs*10
Craniofacial features ablepharon, absent zygoma, bilateral
anotia, cleft palate, underdeveloped
maxilla, micrognathia (severe)
bilateral choanal atresia, upper
lower eyelid clefts, microcepha
Limb features bowed femora, flared metaphyses (lower
extremities), dysplastic acetabulae,
delayed ossification of epiphyses
none
Developmental features essentially normal at 2 years of age
(mild communication delay)
normal at 6 years of age
Other short stature patent ductus arteriosus
aGenBank: NM_015425.3.
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cartilage at 5 dpf (Figure 5), consistent
with jaw agenesis.
The vertebrate craniofacial skeleton
is derived primarily from NCCs, a
migratory progenitor cell popula-tion.25 Given the craniofacial phenotypes observed in
polr1a mutant zebrafish and in the three humans with
acrofacial dysostosis, Cincinnati type, we hypothesized
that polr1a is functionally required in NCC development.
We examined polr1a mutant embryos for evidence of de-
fects in NCC formation, migration, and differentiation
(Figure 6). By 12 hpf, the neural plate appeared normal
in polr1a mutant embryos, as evidenced by the normal
pattern of sox2 expression. However, altered expression
of sox10, which demarcates NCCs migrating from the neu-
ral plate, was coincident with the craniofacial phenotype.
The number of sox10-positive migratory NCCs was notice-
ably lower in 17-hpf polr1a mutant embryos than in wild-
type controls. This reduction persisted in 24-hpf polr1a
mutant embryos. Consistent with this reduction, immu-
nostaining for HuC revealed that the cranial ganglia,1A3
c.3895G>T
p.Val1299Phe
and
ly
down-slanting palpebral fissures,
malar flattening, unilateral microtia,
micrognathia (mild)
short, broad fingers and toes
normal at 52 years of age
–
Figure 3. In Situ Hybridization for polr1a at Various Zebrafish Stages Reveals a Dynamic Expression Pattern
Maternal expression of polr1awas present at the 2-cell stage (A) but was not detected at 6 hpf (C). polr1awas ubiquitously expressed at 12
hpf (E), coincident with early NCCmigration, andwas expressed at 18 hpf in regions of the brain, eye, and somites (G). At 24 hpf, expres-
sion was present in the eye, midbrain-hindbrain boundary, otic vesicle, and somites (I). Beyond 36 hpf, expression was much reduced
and was present in the lens of the eye and the midbrain-hindbrain boundary (K). The same expression was seen at 48 hpf (M), at which
time additional expression was observed in the developing liver, which was clearly present at 72 hpf (O). The sense probe (B, D, F, H, J, L,
N, and P) showed no signal at each stage examined. Scale bars represent 200 mm.derived in part from sox10-positive NCCs, were hypoplas-
tic in 3-dpf polr1a mutant embryos (Figure 5).
Similar to the reduction in sox10-labeled neurogenic pre-
cursor cells, a striking reduction in NCC-derived cartilage
precursors was denoted via sox9a expression in 24-hpf
polr1amutant embryos (Figure 6). Furthermore, the expres-
sion of dlx2a, a marker of NCCs within the branchial
arches, illustrated smaller and fewer branchial arches in
polr1a mutants than in wild-type fish (four in mutants
versus five in wild-type fish; Figure 6). Collectively, the
reduction in sox9-, sox10-, and dlx2-labeled NCCs and
the hypoplasia of the cranial ganglia, branchial arches,
and jaw strongly support that NCC deficiency underlies
the cranioskeletal defects observed in polr1a mutant em-
bryos and in humans with acrofacial dysostosis, Cincin-
nati type.
The NCC deficiency could arise through perturbation of
NCC progenitor development at the induction or migra-
tion stages. To discriminate between these possibilities,
we assayed for apoptosis via TUNEL staining and for
migrating NCCs in polr1a; sox10:gfp transgenic embryos
at 14 hpf and also via Sox10 immunostaining in 24-hpf
embryos. Early in NCC migration, at 14 hpf,
polr1ahi3639Tg/hi3639Tg; sox10:gfp embryos displayed more
apoptosis than did wild-type controls (Figures 7A–7D).
However, the TUNEL stain did not significantly co-localize
with sox10:gfp expression, suggesting that the migratoryThe AmNCC population was not undergoing apoptosis. Confirm-
ing these observations, at 24 hpf, apoptosis was present
within the neural tube (Figures 7E–7J). Cross-sections
through the neural tube revealed elevated apoptosis in
the dorsal NCC progenitor domain (Figures 7H and 7J).
These observations suggest that polr1a is required for neu-
roepithelial cell survival and the generation of NCCs but is
not essential for the viability of migrating NCCs. Thus, the
NCC deficiency in polr1amutant embryos is mainly due to
a reduction in the NCC progenitor pool, which diminishes
the generation of migratory NCCs.
Polr1a composes the largest subunit of RNA polymerase
I, which plays a key role in transcribing ribosomal RNA
during the process of ribosome biogenesis. Given that
ribosome biogenesis is essential for cell growth and
proliferation26 and that rDNA transcription is one of the
rate-limiting steps of ribosome biogenesis,27,28 we hypoth-
esized that polr1a might regulate NCC progenitor cell sur-
vival in zebrafish by playing a key role in rDNA transcrip-
tion. We determined the levels of rRNA transcription via
qRT-PCR in 24-hpf embryos with primers designed against
regions of the initial, unprocessed transcript (47S). All
three regions of the unprocessed transcript were signifi-
cantly reduced (p < 0.01) in polr1ahi3639Tg/hi3639Tg em-
bryos, such that their production levels were less than
half of those in wild-type controls (Figure 8). Furthermore,
the 18S transcript, which includes both the stableerican Journal of Human Genetics 96, 765–774, May 7, 2015 769
Figure 4. Phenotype of polr1ahi3639Tg/hi3639Tg Zebrafish from 15 hpf to 4 dpf
At 15 hpf, compared to wild-type siblings (A), mutant embryos first appeared with a grainy and irregular shape to the anterior region (B).
This persisted through 24 hpf, when the cranial phenotype was more pronounced, the eyes were smaller, and the somites were wider (D)
than those in wild-type siblings (C). At 34 hpf, pigment formation was clearly slower in mutant embryos than in wild-type siblings (E),
and a bit of pericardial edema began to appear in mutant embryos (F). By 72 hpf, there was a clear lack of the ceratohyal and ceratobran-
chial cartilage (arrows point to cartilage in G and to the absence of these elements in H). Mutant embryos were smaller than wild-type
siblings at 3 dpf (I and J) and 4 dpf (K and L). They showed much smaller eyes and otic vesicles and very small pectoral fins, failed to
inflate their swim bladder, and had varying degrees of pericardial edema. Some mutants died by 4 dpf, and others died at 5 dpf, which
was most likely due to cardiovascular defects. Scale bars represent 200 mm.processed form and the unprocessed 47S, was also consid-
erably reduced in polr1ahi3639Tg/hi3639Tg embryos. These re-
sults indicate that 47S production is disrupted in polr1a
mutant embryos, compromising ribosome biogenesis and
consequently NCC progenitor survival.
Deficient ribosome biogenesis is known to cause nucle-
olar stress activation of p53.29 Therefore, we hypothesized
that the cell death observed in polr1a mutant embryos
might be p53 dependent. We examined polr1a mutant
embryos for activation of tp53 and Tp53 via qRT-PCR
and immunoblot, respectively. tp53 transcript levels werecranial ganglia were present inmutant embryos (F), but they were sma
Tg, trigeminal ganglion; aLLG, anterior lateral line ganglion; F, faci
lateral line ganglion; G, glossopharyngeal ganglion; V, vagal ganglia
770 The American Journal of Human Genetics 96, 765–774, May 7, 24-fold higher in 24-hpf polr1a mutant embryos than in
wild-type controls, and the protein levels showed a 1.2-
fold increase at 4 dpf (Figures 8B and 8C).Discussion
POLR1A encodes subunit A190, the largest subunit of
RNA polymerase I, which plays a key role in transcribing
ribosomal RNA during the process of ribosome biogen-
esis. S. cerevisiae and human A190 proteins are 40%Figure 5. polr1ahi3639Tg/hi3639Tg Embryos
Show Reduced Formation of NCC-Derived
Elements
Alcian blue staining at 5 dpf (A–D) shows
that whereas elements of the neurocra-
nium (such as the trabeculae) were present
in both wild-type and mutant embryos
(red arrows), very little of the viscerocra-
nium was present in mutant embryos
(D). Some cartilage in the region of the
jaw was faintly present in mutant em-
bryos. It is possible that this could be
Meckel’s cartilage (black arrows). A smaller
region of Alcian blue staining posterior to
the black arrow could potentially be the ce-
ratohyal. There was also a small remnant
of staining in the pectoral fin (green arrows
in A and B) in the mutant embryos. Scale
bars in (A)–(D) represent 200 mm. Immu-
nostaining for HuC at 82 hpf (E and F)
shows reduced and delayed neuronal
development in mutant embryos. All
ller than those in control siblings (E). Abbreviations are as follows:
al ganglion complex; SA, statoacoustic ganglion; pLLg, posterior
. Scale bars in (E) and (F) represent 100 mm.
015
Figure 6. In Situ Hybridization for
Markers of NCC Development
In situ hybridization for sox2 (A–D) and
sox10 (E–H) at 12 hpf shows that levels of
NCC induction were relatively similar be-
tween mutant embryos and wild-type sib-
lings. At 17 hpf, soon after the onset of a
visible mutant phenotype, the level of
sox10 staining was lower in mutant em-
bryos (J and L) than in wild-type controls
(I and K), indicating a reduced migratory
NCC population. By 24 hpf, the popula-
tion of cartilage precursors labeled by
sox9a (M–P) showed a strong reduction
throughout mutant embryos, especially
in the pharyngeal arches (N and P). The
population of NCCs in the pharyngeal
arches (shown by dlx2a in situ at 36 hpf
in Q–T) was also reduced in mutant em-
bryos (R and T). The mutant embryos
showed overall diminished staining and a
lack of the fifth arch. Scale bars represent
200 mm.homologous overall and have increased homology in the
active site and DNA-binding cleft domains (Table S7).
The crystal structure of RNA polymerase I in S. cerevisiae re-
vealed that subunits A190 and A135 interface to form a
composite active site. Subunit A190 forms a ‘‘shelf’’ mod-
ule that interacts with the ‘‘core’’ module, subunit A135.
The cleft between A190 and A135 must contract, via rota-
tion of the core and shelf modules, so that a conserved
aspartate loop within the cleft can bind two catalytic metal
ions and the RNA 30 end.30 Here, we have presented three
individuals with phenotypes ranging from mild isolated
mandibulofacial dysostosis to severe acrofacial dysostosis
and heterozygous variants in POLR1A. Supporting the hy-
pothesis that POLR1A dysfunction causes these pheno-
types, in vivo studies of polr1a expression and function
in zebrafish demonstrated that zebrafish polr1a mutants
exhibit cranioskeletal defects that mimic the severe pheno-
type found in individual 1A1. Notably, the tissues that
were affected in both affected humans and mutant zebra-
fish correlate with the domains of enriched polr1a expres-The American Journal of Humasion during embryogenesis. Taken
together, our data indicate that
polr1a loss of function compromises
rDNA transcription, one of the rate-
limiting steps in the process of ribo-
some biogenesis. Deficient ribosome
biogenesis in turn leads to activa-
tion of p53-dependent cell death,
which diminishes the generation of
migrating NCCs and results in the
cranioskeletal hypoplasia character-
istic of acrofacial dysostosis, Cincin-
nati type (Figure S3). Our data are
consistent with those of in vitro
studies that demonstrated that in hu-
man cancer cells, POLR1A silencingleads to increased apoptosis via p53-dependent path-
ways.31,32 Collectively, these studies demonstrate the crit-
ical importance of polr1a in cell survival, as well as in
bone and cartilage development during embryogenesis.
Furthermore, they support the classification of acrofacial
dysostosis, Cincinnati type as a ribosomopathy.
The specific mechanism underpinning femoral bowing,
metaphyseal flaring, and delayed epiphyseal ossification in
individual 1A1 is not yet understood. However, limb ab-
normalities are a characteristic feature of Nager syndrome,
and femoral bowing has been observed in association with
bent-bone dysplasia syndrome (BBDS [MIM: 614592]).
Although Nager syndrome is caused by mutations in
SF3B4 (MIM: 605593)8 and BBDS is caused by mutations
in FGFR2 (MIM: 176943),33 both conditions are associated
with perturbed ribosome biogenesis. Interestingly, RUNX2
is essential for osteoblast differentiation and has been
shown to associate with the RNA polymerase I regulator
complex and repress the rDNA promoter and thus
influence rRNA synthesis.34 Furthermore, mutations inn Genetics 96, 765–774, May 7, 2015 771
Figure 7. TUNEL Staining Reveals Increased Cell Death in
Mutant Embryos
Cell death was present throughout the polr1ahi3639Tg/hi3639Tg
embryos at both 14 and 24 hpf and was especially high within
the neural tube. At 14 hpf (A–D), TUNEL staining did not sig-
nificantly co-localize with the migratory NCC population, as
shown by sox10:gfp expression. Scale bars in (A)–(D) represent
200 mm. At 24 hpf (E–J), cross-sections through the embryos
showed cell death in the dorsal portion of the neural tube in
mutant embryos (H and J), whereas control embryos did not
show cell death in this location (G and I). Scale bars in (E)–(J) repre-
sent 100 mm.
Figure 8. qRT-PCR for rRNA Transcripts Shows a Significant
Reduction in polr1ahi3639Tg/hi3639Tg Embryos, whereas tp53 Levels
Are Increased
(A) The level of ITS1 in mutant embryos was 23% of that in wild-
type siblings, the level of ITS2 was 41%, and the level of the 50
externally transcribed sequence (ETS) was 24%. The 18S levels
also tended to be lower in mutants (71%) than in wild-types
(100%), but this difference was not significant (p ¼ 0.095). qRT-
PCR showed a 4-fold increase in the transcription of tp53 in polr1a
mutant embryos at 24 hpf, which is when rRNA transcription
diminished. Error bars represent 95% confidence intervals.
(B) Immunoblot analysis was used to determine levels of Tp53.
Lane 1 shows the control, lane 2 shows the polr1ahi3639Tg/hi3639Tg
embryo, and lane 3 shows the negative control. The red signal is
a-tubulin, and the green signal is Tp53.
(C) Quantification of immunoblots in ImageJ revealed that the
levels of Tp53 were significantly higher (p ¼ 0.007) in mutant em-
bryos than in wild-type siblings at 4 dpf. *p < 0.01. Error bars
represent 95% confidence intervals.RUNX2 (MIM: 600211) are known to cause cleidocranial
dysplasia (MIM: 119600), which is characterized by cra-
nioskeletal anomalies together with decreased bone den-
sity.35 Together, these studies demonstrate an important
role for ribosome biogenesis in limb and general skeletal
development7 and imply that the limb skeletal defects
associated with acrofacial dysostosis, Cincinnati type
might also be caused by perturbed ribosome biogenesis.772 The American Journal of Human Genetics 96, 765–774, May 7, 2The phenotypic specificity observed in humans and ze-
brafish with abnormal function of POLR1A and polr1a,
respectively, suggests that certain tissues require threshold
levels of ribosomes for normal development or that they
might be particularly sensitive to perturbations in ribo-
some biogenesis. This phenomenon appears to be
common to ribosomopathies. Nager syndrome, Treacher
Collins syndrome, and Diamond Blackfan anemia all
involve similar craniofacial malformations consistent
with mandibulofacial dysostosis, but they are also associ-
ated with syndrome-specific defects such as limb or blood
anomalies despite disruptions of the same global pro-
cess.6,7,36 Differential regulation of rRNA, ribosomal pro-
tein activity, or protein translation in distinct tissues could
mechanistically underlie the phenotypic specificity of
each ribosomopathy despite disruption of the same puta-
tively ubiquitous ribosome-biogenesis process. This vari-
ability in threshold ribosome levels might also underlie
the phenotypic variability between affected individuals if
certain mutations cause less of a disturbance to ribosome
biogenesis.
Further study of mutation-specific POLR1A dysfunction
might help elucidate the specific roles of ribosome biogen-
esis in chondrogenesis and osteogenesis and account for
the disparate phenotypes of the three individuals we
have described here. The variable severity might also corre-
late with the location or type of mutation in POLR1A or
alternatively be due to as yet unidentified genetic modi-
fiers, as has been suggested to underlie phenotypic015
variability in Treacher Collins syndrome.37 It is of partic-
ular interest that the most severely affected individual,
IA-1, has a missense variant in the catalytic site
(p.Glu593Gln) of the protein A190 (Figure S4). The wild-
type glutamic acid residue at position 593 is adjacent to a
highly conserved D-D-D motif, which forms an aspartate
loop and coordinates binding of two catalytic metal ions
when the protein is in its contracted, active state.30 Indi-
vidual 1A2, with an intermediate phenotype between
those of 1A1 and 1A3, has a frameshift variant predicted
to truncate the protein and thus remove a portion of the
second cleft domain and all of the jaw, expander, and third
cleft domains (Figure S4). Individual 1A3, with the mildest
craniofacial phenotype, has a missense variant affecting
the jaw domain of the protein (Figure S4). The expander,
which is connected to the jaw, stabilizes the cleft between
A190 and A135 when it is open and inactive.10 Although
the frameshift variant in individual 1A2 was inherited
from her very mildly affected father, this does not preclude
the variant from causality. It is well known that the pheno-
type of Treacher Collins syndrome is variable, given that
documented cases of family members have identical muta-
tions with markedly different expression.38 Individuals
1A2 and 1A3 did not undergo exome sequencing for
excluding the possibility of additional genetic diagnoses.
However, the index affected individual, 1A1, did undergo
exome analysis, and no additional putative variants were
identified. Therefore, the likelihood of an alternative pri-
mary genetic explanation for the phenotypes of 1A2 and
1A3 is extremely low.
In conclusion, our description of the etiology and path-
ogenesis of acrofacial dysostosis, Cincinnati type as a ribo-
somopathy arising frommutations in POLR1A provides an
opportunity to gain further insight into the impact of
disordered ribosome biogenesis on craniofacial and limb
skeletal development. Additionally, it represents a starting
point for exploring possible avenues for prevention,
similar to what has been accomplished with Treacher
Collins syndrome.4,5Supplemental Data
Supplemental Data include four figures and seven tables and can
be found with this article online at http://dx.doi.org/10.1016/j.
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